Target intelligence / Profile preview

TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 (TAB1) (TAB1)

Target
TAB1
Molecular classification
Adaptor protein, Pseudophosphatase, Other
01

Overview

TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 (TAB1) is a crucial adaptor protein and pseudophosphatase that plays a pivotal role in intracellular signaling cascades. It constitutively associates with the N-terminal catalytic domain of MAP3K7 (also known as TAK1), facilitating its autophosphorylation and subsequent activation in response to pro-inflammatory cytokines, Toll-like receptor (TLR) ligands, and TGF-beta. Additionally, TAB1 directly interacts with and induces the non-canonical autoactivation of MAPK14 (p38alpha), representing an alternative pathway to classical MAPKK activation. Through these interactions, TAB1 serves as a key mediator of downstream NF-kappa-B and MAPK signaling pathways, which regulate essential cellular processes such as inflammation, immune responses, cell survival, and apoptosis.\n\nDysregulation of TAB1-mediated signaling is heavily implicated in chronic inflammatory disorders, autoimmune diseases, and various cancers, where it promotes tumor cell survival, invasion, and metastasis. Consequently, the TAK1-TAB1 complex and the p38alpha-TAB1 interaction have emerged as attractive therapeutic targets. While direct small-molecule inhibitors of TAB1 are still in early development, several pharmacological agents, such as the selective TAK1 inhibitor takinib and the type II inhibitor NG25, target the active TAK1-TAB1 complex to suppress downstream inflammatory signaling. Furthermore, targeting the specific protein-protein interaction interface between p38alpha and TAB1 with small molecules or peptide inhibitors represents a promising strategy to selectively block stress-induced p38alpha activation while avoiding the systemic toxicities associated with global p38alpha kinase inhibition.

Other names
Mitogen-activated protein kinase kinase kinase 7-interacting protein 1TGF-beta-activated kinase 1-binding protein 1TAK1-binding protein 1MAP3K7IP13'-Tab1
02

Mechanism of action

Inhibition of the TAK1-TAB1 complex, disruption of the p38-TAB1 protein-protein interaction, or allosteric modulation of downstream kinase activation.

03

Biological functions

Signal transductionImmune responseApoptosisInflammationCell survivalMAPK pathway activationNF-kappa-B pathway activation
04

Disease associations

CancerInflammationAutoimmune diseaseCardiovascular diseaseOther
05

Safety considerations

Embryonic lethalityBroad immunosuppressionOff-target kinase inhibitionDisruption of multiple downstream signaling pathways
06

Interacting drugs

4 more in the full profile.

07

Biomarkers

Phospho-p38 MAPKPhospho-TAK1NF-kappa-B activationTAB1 expression levelPhospho-TAB1 (Ser423)

Beyond the preview

Go deeper on TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 (TAB1) (TAB1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 (TAB1) (TAB1).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call